Highlights
- Sales over the Year and quarter: The company’s sales declined by -5.35 % over the year, decrease in net sales/revenue by -5.01 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 120 %. Marginal increase in other income during this quarter, up by 120%.
- Profit over the Year and quarter: Significant improvement in profitability for Colinz Laboratories ltd.. Notable increase of 6.25 % in net profit Year to Year, Colinz Laboratories ltd.’s profitability increased by 28.3 % in this quarter.
- EPS over the Year and quarter: EPS increased by 5.88 % Year to Year. EPS increased by 28.57 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1.721 Cr | Rs. 1.715 Cr | Rs. 1.629 Cr | -5.01 % | -5.35 % |
Expenses | Rs. 1.56 Cr | Rs. 1.57 Cr | Rs. 1.5 Cr | -4.46 % | -3.85 % |
Operating Profit | Rs. 0.16 Cr | Rs. 0.15 Cr | Rs. 0.13 Cr | -13.33 % | -18.75 % |
OPM % | 9.3 % | 8.75 % | 7.98 % | -0.77 % | -1.32 % |
Other Income | Rs. 0.05 Cr | Rs. 0.05 Cr | Rs. 0.11 Cr | + 120 % | + 120 % |
Interest | Rs. 0.01 Cr | Rs. 0.01 Cr | Rs. 0.01 Cr | + 0 % | + 0 % |
Depreciation | Rs. 0.03 Cr | Rs. 0.03 Cr | Rs. 0.03 Cr | + 0 % | + 0 % |
Profit before tax | Rs. 0.17 Cr | Rs. 0.16 Cr | Rs. 0.2 Cr | + 25 % | + 17.65 % |
Tax % | 18.99 % | 27.4 % | 28.42 % | + 1.02 % | + 9.43 % |
Net Profit | Rs. 0.13 Cr | Rs. 0.11 Cr | Rs. 0.14 Cr | + 27.27 % | + 7.69 % |
EPS in Rs | Rs. 0.51 | Rs. 0.42 | Rs. 0.54 | + 28.57 % | + 5.88 % |
Today, we’re looking at Colinz Laboratories ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -5.35 %. However, it did see a marginal slip of -5.01 % from the previous quarter. Expenses decreased slightly by -4.46 % quarter-on-quarter, aligning with the annual decline of -3.85 %. Operating profit, while down -18.75 % compared to last year, faced a quarter-on-quarter dip of -13.33 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.32 %, but a shrinkage of -0.77 % sequentially. Other income rose by 120 % compared to the last quarter, despite an annual growth of 120 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year increase remains at a moderate 0 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax grew annually by 17.65 % but saw an increase from the preceding quarter by 25 %.
Tax expenses as a percentage of profits increased slightly by 9.43 % compared to last year, with a more notable quarter-on-quarter increase of 1.02 %. Net profit rose by 7.69 % year-on-year but experienced a 27.27 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 5.88 % but a quarterly rise of 28.57 %. In summary, Colinz Laboratories ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1.721 Cr | Rs. 1.715 Cr | Rs. 1.629 Cr | -5.01 % | -5.35 % |
Expenses | Rs. 1.56 Cr | Rs. 1.57 Cr | Rs. 1.5 Cr | -4.46 % | -3.85 % |
Operating Profit | Rs. 0.16 Cr | Rs. 0.15 Cr | Rs. 0.13 Cr | -13.33 % | -18.75 % |
Net Profit | Rs. 0.13 Cr | Rs. 0.11 Cr | Rs. 0.14 Cr | + 27.27 % | + 7.69 % |
EPS in Rs | Rs. 0.51 | Rs. 0.42 | Rs. 0.54 | + 28.57 % | + 5.88 % |
In reviewing Colinz Laboratories ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -5.35 % year-on-year, although there was a slight dip of -5.01 % from the previous quarter. Expenses decreased by -3.85 % compared to the previous year, with a decrease of -4.46 % quarter-on-quarter. Operating Profit dropped by -18.75 % annually, and saw a -13.33 % decrease from the last quarter.
Net Profit showed yearly increase of 7.69 %, and experienced a 27.27 % increase from the previous quarter. Earnings Per Share (EPS) rose by 5.88 % annually, however rose by 28.57 % compared to the last quarter. In essence, while Colinz Laboratories ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.